Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Amides Stories

2014-03-24 08:28:21

Presentations to include research around antidote for dabigatran, a post-hoc analysis of data from the RE-LY® trial and data from the GLORIA(TM)-AF registry RIDGEFIELD, Conn., March 24, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that data from three company-sponsored PRADAXA studies will be presented at the American College of Cardiology 63(rd) Annual Scientific Session (ACC.14) in Washington, D.C., March 29 to 31, 2014. An oral presentation will...

2014-03-24 08:26:49

Results Show Highest Rate of Control Ever Observed with Warfarin in Real-world Setting, Surpassing Thresholds for Cost-Effectiveness of Newer Agents Identified in Five Recent Independent Studies WALTHAM, Mass., March 24, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR) today announced the publication of the largest-ever study of warfarin patient self-testing, which demonstrated that weekly International Normalized Ratio (INR) testing significantly improves control of warfarin, as measured...

2014-03-23 23:01:59

Federal Judge Overseeing More than 2,300 Pradaxa Lawsuits Schedules Four Bellwether Trials, First of Which Will Begin in September 2014. Columbus, OH (PRWEB) March 23, 2014 The federal judge overseeing thousands of Pradaxa lawsuits in the U.S. District Court, Southern District of Illinois, has established new dates for the litigation’s first bellwether trials, Wright & Schulte LLC reports. According to a Pretrial Order issued on March 5, 2014, by U.S. District Judge David Herndon,...

2014-03-19 23:29:43

http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news. Visit the DrugNews Center today. New York, NY (PRWEB) March 19, 2014 The prescription drug safety advocates at DrugNews.net are alerting patients taking the blood thinner Pradaxa of new information on the site. Updated court records show the number of lawsuits alleging the drug caused internal bleeding have risen from February to March*. DrugNews is a free resource...

2014-03-14 23:26:28

The DrugRisk Center is the largest source on the Web for information on prescription drug research, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) March 14, 2014 The prescription drug safety center DrugRisk.com is announcing updated legal news on the site for patients taking the blood thinner Pradaxa. Recent court records show the number of lawsuits alleging the drug caused internal bleeding injury or death have risen for the month of March*. DrugRisk...

2014-03-12 23:31:01

Key trials are scheduled over allegations that Pradaxa may cause serious bleeding problems. National network of attorneys continues policy of no-cost consultations to consumers inquiring about legal options to seek compensation over these allegations. San Diego, CA (PRWEB) March 12, 2014 http://www.resource4thepeople.com/defectivedrugs/pradaxa-lawsuits.html Resource4thePeople today announced its latest informational update for consumers following lawsuits* alleging that the popular...

2014-03-11 23:30:43

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today. New York, NY (PRWEB) March 11, 2014 The prescription drug safety center DrugNews.net is announcing new information on the site about the blood thinner Pradaxa. A new report shows the Food and Drug Administration of Jordan recently approved the popular drug, marking the 100th country to authorize its use*. DrugNews is a free...

2014-03-11 04:21:19

WHIPPANY, N.J., THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., March 11, 2014 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR(®) (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not...

2014-03-10 23:27:46

National network of lawyers continues offer of complimentary consultations to consumers seeking compensation in lawsuits alleging links between diabetes medications Byetta, Januvia, Janumet and Victoza and pancreatic cancer. San Diego, CA (PRWEB) March 10, 2014 http://www.resource4thepeople.com/defectivedrugs/byetta.html Resource4thePeople announced today its latest update for consumers following allegations in lawsuits* claiming that the use of the diabetes medication Byetta and other...

2014-03-09 23:01:44

The Firm is actively filing Pradaxa bleeding lawsuits on behalf of patients who may have suffered side effects caused by the blood thinner manufactured by Boehringer-Ingelheim. New York, NY (PRWEB) March 09, 2014 Pradaxa lawsuit (http://www.pradaxalawsuithelp.com/) plaintiffs who may have experienced dangerous episodes of internal bleeding may be one step closer to arguing their cases in court, with the first of four bellwether trials slated to begin in September, Bernstein Liebhard LLP...